GAP production of TCM herbs in China

Planta Medica

Volumn 76, Issue 17, 2010, Pages 1948-1955

  Zhang, Bengang ^a   Peng, Yong ^a   Zhang, Zhao ^a   Liu, Haitao ^a   Qi, Yaodong ^a   Liu, Shuang ^b   Xiao, Peigen ^a  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^b Food and Drug Administration   (China)

Author keywords

China; cultivation; GAP; GAP base; TCM herbs

Indexed keywords

CHINESE DRUG;

CERTIFICATION; CHINA; CHINESE MEDICINE; HERB; HUMAN; NONHUMAN; PRACTICE GUIDELINE; QUALITY CONTROL; REVIEW; SPECIES CULTIVATION; STANDARD;

AGRICULTURE; CERTIFICATION; CHINA; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; QUALITY CONTROL;

EID: 78649903606     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1250527     Document Type: Review

References (17)

1. Ren D Q., Zhou R H. Good agricultural practice (GAP) implementation guide for Chinese Crude Drug. Beijing China Agricultural Press 2003
2. Qin L P., Huang B K., Zheng H C. The background, present situation, problem and tactics of GAP of Chinese materia medica. J Pharm Pract 2001 19 67-70
3. Yao L, Cheng H Z., Yang Z. Guidelines for good agricultural practice of Chinese crude drugs. Beijing China Agriculture Press 2006
4. Wei J H., Chen S L., GUO QS. Analysis on GAP implementation of China's current situation and development. Res Inf Tradit Chin Med 2004 6 4-8
5. Zheng Y C., Bao C Y. Industry improved by science and technologyExhibition of industrial base construction of Jilin traditional Chinese medicine modernization. Beijing Science and Technology Daily November 30 2009
6. Chen S L. Sustaining Herbal Supplies: China. Sharing innovative experiences (Vol. 10): examples of the development of pharmaceutical products from medicinal Plants. New York UNDP 2005 157-163
7. Liu S, Wei J H., Chen S L. Study on criteria for GAP certification of wild tending species of Chinese crude drug. Chin Med J Res Pract 2005 7 1-4
8. Ran M X. The developmental situation and prospect of planting Chinese material medica in China. Mod Chin Med 2008 10 3-6
9. Liu Y H. National S & T development strategy for modernization of traditional Chinese medicine. Mod Tradit Chin Med Mater Med 2005 7 1-4
10. Yu P M., Wang J H., Li H, Zhang N. Probe on the industrialization pattern of Chinese material medica in GAP times. Lishizhen Med Mater Med Res 2007 17 665-666
11. Wang J Q., Zhang A, Liu Y L., Lu D G., Zhang B, Cui J H. Countermeasures and proposals for implement of GAP normalized cultivation of Chinese medicinal materials. Mod Tradit Chin Med Mater Med 2005 7 74-77
12. Zhu L X. The relationship research of the Chinese medicine herbs implement GAP cultivation and the superior medicine herbs. Lishizhen Med Mater Med Res 2006 17 F0003-F0004
13. Liu Y M., Feng Q J., Niu X. The characters and problems of Chinese GAP cultivation of traditional medical material. J Shanxi Coll Tradit Chin Med 2002 3 46-48
14. Li L Y., Xiao X H., Win S Y. Probe on the formation and differentiation of Dao Di Chinese crude drug. Chin J Tradit Med Sci Technol 1996 6 104-106
15. Huang L Q., Zhang R X. Biological investigation on the Dao Di Chinese crud drug. Chin Pharm J 1997 32 563-566
16. Ding L W. Why did the price of Schisandra chinesis plunge so quickly? The marketing analysis of this species between 2000 and 2010. Mod Chin Med 2009 11 48-50
17. Kong L, Qin J X. GAP is a propeller making traditional Chinese medicine into the world. Chin Pharmacol 2003 12 7-9